Early intensification of therapy for type 2 diabetes mellitus and achievement of the target level of glycohemoglobin HbA 1c  are necessary factors to reduce the risk of micro- and macrovascular complications

M. S. Shamkhalova; O. Y. Sukhareva

doi:10.14341/DM13079-10249

For citations:

Shamkhalova M.S., Sukhareva O.Y. Early intensification of therapy for type 2 diabetes mellitus and achievement of the target level of glycohemoglobin HbA_1c are necessary factors to reduce the risk of micro- and macrovascular complications. Diabetes mellitus. 2023;26(4):343-351. (In Russ.) https://doi.org/10.14341/DM13079

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

For citations:

Cookies policy